FDA recall D-0100-2021

Teva Pharmaceuticals USA · Class III · drug

Product

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Reason for recall

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Distribution

Product was distributed Nationwide in the USA.

Key facts

Status
Terminated
Initiation date
2020-11-11
Report date
2020-11-25
Termination date
2021-06-24
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0100-2021